Athanasios Fassas

8.9k total citations · 2 hit papers
79 papers, 6.1k citations indexed

About

Athanasios Fassas is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Athanasios Fassas has authored 79 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Hematology, 37 papers in Oncology and 30 papers in Molecular Biology. Recurrent topics in Athanasios Fassas's work include Multiple Myeloma Research and Treatments (60 papers), Hematopoietic Stem Cell Transplantation (20 papers) and Cancer Treatment and Pharmacology (19 papers). Athanasios Fassas is often cited by papers focused on Multiple Myeloma Research and Treatments (60 papers), Hematopoietic Stem Cell Transplantation (20 papers) and Cancer Treatment and Pharmacology (19 papers). Athanasios Fassas collaborates with scholars based in United States, Austria and Germany. Athanasios Fassas's co-authors include Bart Barlogie, Guido Tricot, Maurizio Zangari, Elias Anaissie, Nikhil C. Munshi, Frits van Rhee, Christopher Morris, John D. Shaughnessy, Firas Muwalla and John Crowley and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Athanasios Fassas

79 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma

2006 532 citations Bart Barlogie, Guido Tricot et al. profile →
Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells

2002 507 citations Maurizio Zangari, Elias Anaissie et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Athanasios Fassas United States	41	5.0k	2.9k	2.5k	805	540	79	6.1k
Patrizia Tosi Italy	35	5.2k 1.0×	3.6k 1.2×	3.0k 1.2×	1.0k 1.3×	394 0.7×	146	6.6k
Natalie S. Callander United States	41	4.0k 0.8×	3.2k 1.1×	2.8k 1.1×	716 0.9×	573 1.1×	199	5.9k
Laura Rosiñol Spain	41	5.1k 1.0×	3.7k 1.2×	2.9k 1.2×	846 1.1×	486 0.9×	219	6.2k
Ingemar Turesson Sweden	46	6.2k 1.2×	4.0k 1.4×	3.5k 1.4×	1.8k 2.2×	716 1.3×	148	8.3k
J. A. Child United Kingdom	31	5.2k 1.0×	3.5k 1.2×	2.9k 1.2×	1.4k 1.7×	775 1.4×	114	6.8k
Jamie Cavenagh United Kingdom	40	4.6k 0.9×	2.5k 0.9×	1.9k 0.7×	1.1k 1.4×	1.8k 3.3×	141	6.7k
Prashant Kapoor United States	40	4.0k 0.8×	3.8k 1.3×	2.3k 0.9×	1.3k 1.6×	504 0.9×	327	6.2k
Luciano J. Costa United States	35	3.2k 0.6×	1.9k 0.7×	2.4k 1.0×	619 0.8×	651 1.2×	256	4.8k
Michel Delforge Belgium	31	2.6k 0.5×	2.1k 0.7×	1.6k 0.6×	646 0.8×	846 1.6×	150	4.4k
E Archimbaud France	34	3.3k 0.7×	2.3k 0.8×	1.4k 0.6×	616 0.8×	480 0.9×	124	5.1k

Countries citing papers authored by Athanasios Fassas

Since Specialization

Citations

This map shows the geographic impact of Athanasios Fassas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Athanasios Fassas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Athanasios Fassas more than expected).

Fields of papers citing papers by Athanasios Fassas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Athanasios Fassas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Athanasios Fassas. The network helps show where Athanasios Fassas may publish in the future.

Co-authorship network of co-authors of Athanasios Fassas

This figure shows the co-authorship network connecting the top 25 collaborators of Athanasios Fassas. A scholar is included among the top collaborators of Athanasios Fassas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Athanasios Fassas. Athanasios Fassas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schmid, Christoph, Myriam Labopin, Arnon Nagler, et al.. (2007). Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party. Journal of Clinical Oncology. 25(31). 4938–4945. 360 indexed citations

Miceli, Marisa H., Dong Lei, Monica Grazziutti, et al.. (2006). Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients. Bone Marrow Transplantation. 37(9). 857–864. 87 indexed citations

Grazziutti, Monica, Dong Lei, Marisa H. Miceli, et al.. (2006). Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model. Bone Marrow Transplantation. 38(7). 501–506. 86 indexed citations

Grazziutti, Monica, Dong Lei, Marisa H. Miceli, et al.. (2006). Recovery from neutropenia can be predicted by the immature reticulocyte fraction several days before neutrophil recovery in autologous stem cell transplant recipients. Bone Marrow Transplantation. 37(4). 403–409. 16 indexed citations

Gojo, Ivana, Barry Meisenberg, Athanasios Fassas, et al.. (2005). Autologous stem cell transplantation followed by consolidation chemotherapy for patients with multiple myeloma. Bone Marrow Transplantation. 37(1). 65–72. 7 indexed citations

Esteve, Jordi, Myriam Labopin, Jürgen Finke, et al.. (2004). Allogeneic Stem-Cell Transplantation for Patients with De Novo Acute Myeloid Leukemia Not in Complete Response: Results of a Survey from the European Group for Blood and Bone Marrow Transplantation (EBMT).. Blood. 104(11). 2302–2302. 3 indexed citations

Lee, CK, Maurizio Zangari, Bart Barlogie, et al.. (2004). Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant. Bone Marrow Transplantation. 33(8). 823–828. 83 indexed citations

Fassas, Athanasios, Susan Ward, Firas Muwalla, et al.. (2003). Myeloma of the Central Nervous System: Strong Association with Unfavorable Chromosomal Abnormalities and Other High-risk Disease Features. Leukemia & lymphoma. 45(2). 291–300. 49 indexed citations

Anaissie, E., Joth Jacobson, Athanasios Fassas, et al.. (2003). Safety of total therapy II with or without thalidomide (THAL) for newly diagnosed myeloma: A study of 475 consecutive patients. Blood. 102(11). 1 indexed citations

10.

Fassas, Athanasios, Bart Barlogie, Susan Ward, et al.. (2003). Survival after relapse following tandem autotransplants in multiple myeloma patients: the University of Arkansas total therapy I experience. British Journal of Haematology. 123(3). 484–489. 11 indexed citations

11.

Jacobson, Joth, Bart Barlogie, John D. Shaughnessy, et al.. (2003). MDS‐type abnormalities within myeloma signature karyotype (MM‐MDS): only 13% 1‐year survival despite tandem transplants. British Journal of Haematology. 122(3). 430–440. 28 indexed citations

12.

Zangari, Maurizio, Bart Barlogie, Raymond Thertulien, et al.. (2003). Thalidomide and Deep Vein Thrombosis in Multiple Myeloma: Risk Factors and Effect on Survival. Clinical Lymphoma. 4(1). 32–35. 86 indexed citations

13.

Barlogie, Bart, Maurizio Zangari, Athanasios Fassas, et al.. (2002). Transplantation as salvage therapy for high-risk patients with myeloma in relapse. Bone Marrow Transplantation. 30(12). 873–878. 31 indexed citations

14.

Desikan, K.R., Guido Tricot, Nikhil C. Munshi, et al.. (2001). Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony‐stimulating factor alone. British Journal of Haematology. 112(1). 242–247. 47 indexed citations

15.

Zangari, Maurizio, Horace J. Spencer, Athanasios Fassas, et al.. (2001). Thalidomide in the management of multiple myeloma. Seminars in Hematology. 38(3). 250–259. 70 indexed citations

16.

Fassas, Athanasios & Guido Tricot. (2001). Results of high-dose treatment with autologous stem cell support in patients with multiple myeloma. Seminars in Hematology. 38(3). 231–242. 19 indexed citations

17.

Fassas, Athanasios, K.R. Desikan, David S. Siegel, et al.. (1999). Tumour lysis syndrome complicating high‐dose treatment in patients with multiple myeloma. British Journal of Haematology. 105(4). 938–941. 33 indexed citations

18.

Aslan, Turan, Athanasios Fassas, Raman Desikan, et al.. (1999). Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy. Bone Marrow Transplantation. 24(5). 505–509. 20 indexed citations

19.

Mehta, Jayesh, Guido Tricot, Sundar Jagannath, et al.. (1998). Salvage autologous or allogeneic transplantation for multiple myeloma refractory to or relapsing after a first-line autograft?. Bone Marrow Transplantation. 21(9). 887–892. 101 indexed citations

20.

Desikan, K.R., Bart Barlogie, Sundar Jagannath, et al.. (1998). Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma.. Journal of Clinical Oncology. 16(4). 1547–1553. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact